stella
beta
Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4) — Stella
Home
/
Stroke, Acute
/
Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)
View on ClinicalTrials.gov
Recruiting
Back to Stroke, Acute trials
Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(5 sites)
France
Hôpitaux Universitaires Henri Mondor APHP, site Albert Chenevier, Créteil
Centre de Médecine Physique et de Réadaptation APAJH de Pionsat, Pionsat
Germany
Schön Klinik, Bad Aibling
Vivantes Klinikum Spandau, Berlin
Spain
Institut Guttmann, Barcelona